CLINICAL_TRIALS
trial_result
· 2016-02-04
Clinical Trial Update: PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia [Phase 1]
Summary
Phase 1 PET imaging study to assess receptor occupancy of brexpiprazole in adults with schizophrenia; completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2016-02-04